医学
肠促胰岛素
超重
2型糖尿病
内科学
重症监护医学
阶段(地层学)
糖尿病
肥胖
内分泌学
生物
古生物学
作者
Ashwin K. Chetty,Ebne Rafi,Natalie Bellini,Natalie Buchholz,Diana Isaacs
标识
DOI:10.1016/j.eprac.2023.12.010
摘要
To review clinical trial data for incretin therapies that are approved or in late-stage development for overweight or obesity management, along with clinical implications of these therapies and future directions.
科研通智能强力驱动
Strongly Powered by AbleSci AI